Kenneth Douglas

1.5k citations

23 papers · 886 indexed · h-index 12

Impact in

Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
Nephrology top 2%
- Renal Diseases and Glomerulopathies

Papers in

Transplantation 3
- Renal Transplantation Outcomes and Treatments 2
Hematology 12
- Hematopoietic Stem Cell Transplantation 8
- Multiple Myeloma Research and Treatments 6
- Acute Myeloid Leukemia Research 4

Co-authors: Peter C. Taylor Maria Herthelius Maryvonne Hourmant Timothy H.J. Goodship Chantal Loirat Yahsou Delmas Camille L. Bedrosian Christoph Licht
Journals: Bone Marrow Transplantation (4 papers)Journal of Clinical Apheresis (3 papers)Blood (3 papers)British Journal of Haematology (2 papers)Transfusion (1 paper)
Partner nations: United Kingdom Italy United States

In The Last Decade

Kenneth Douglas

22 papers receiving 869 citations

Peers

Countries citing papers authored by Kenneth Douglas

Since Specialization

Citations

This map shows the geographic impact of Kenneth Douglas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Douglas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Douglas more than expected).

Fields of papers citing papers by Kenneth Douglas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth Douglas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Douglas. The network helps show where Kenneth Douglas may publish in the future.

Co-authors

The 25 scholars most cited alongside Kenneth Douglas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kenneth Douglas Line = papers co-authored together Kenneth Douglas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	TNF signaling mediates lipopolysaccharide-induced lung epithelial progenitor cell responses in mouse lung organoids Biomedicine & Pharmacotherapy ·Miguel Angel Manica-Malcom, ユウヨンキム, Kenneth Douglas, M. Cierpka, Ulrich Eisel, Barbro N. Melgert, Reinoud Gosens, Martina Schmidt	2024	1
2	UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high‐dose chemoradiotherapy for patients with malignancy Journal of Clinical Apheresis ·Kenneth Douglas, Maria Gilleece, Patrick Hayden, Hannah Hunter, Peter Johnson, 奥家敏和, Ram Malladi, Shankara Paneesha, Rachel Pawson, Fusheng Zhou, Kavita Raj, Deborah Richardson, Stephen Robinson, Nigel H. Russell, John A. Snowden, Anna Sureda, Eleni Tholouli, Kirsty Thomson, Mike Watts, Keith Wilson	2017	39
3	Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies Kidney International ·Christoph Licht, Larry A. Greenbaum, Petra Muus, Sunil Babu, Camille L. Bedrosian, David J. Cohen, Yahsou Delmas, Kenneth Douglas, Richard R. Furman, Osama Gaber, Timothy H.J. Goodship, Maria Herthelius, Maryvonne Hourmant, Christophe Legendre, Giuseppe Remuzzi, Neil Sheerin, Antonella Trivelli, Chantal Loirat	2015	296
4	Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products Transfusion Medicine ·Catherine Howell, Kenneth Douglas, Isabella Peretti, Isabelle Rodrigues Menezes, Peter C. Taylor, C Maxwell, Patricija Juračić, Carl Haegerl	2015	36
5	Eculizumab (ECU) safety and efficacy in atypical hemolytic uremic syndrome (aHUS) patients with long disease duration and chronic kidney disease (CKD): 2-year results Christoph Licht, Petra Muus, Christophe Legendre, Kenneth Douglas, Maryvonne Hourmant, Yahsou Delmas, Maria Herthelius, Antonella Trivelli, Timothy H.J. Goodship, Camille L. Bedrosian, Chantal Loirat	2015	0
6	European data on stem cell mobilization with plerixafor in patients with nonhematologic diseases: an analysis of the European consortium of stem cell mobilization Transfusion ·Nina Worel, Jane F. Apperley, Grzegorz Basak, Kenneth Douglas, Ian H Gabriel, Catarina Geraldes, Kai Hübel, Ozren Jakšić, Zdeněk Kořı́stek, Francesco Lanza, Roberto M. Lemoli, Gábor Mikala, Dominik Selleslag, Rafael F. Duarte, Mohamad Mohty	2012	16
7	Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial Haematologica ·Noah A. Russell, Kenneth Douglas, Anthony D. Ho, Mohamad Mohty, Kristina Carlson, G.J. Ossenkoppele, Giuseppe Milone, Lingcong She, Junji Fugita, Шэ Сяолин, Noel J. Whitaker, Christian Chabannon	2012	41
8	Eculizumab (ECU) Safety and Efficacy in Atypical Hemolytic Uremic Syndrome (aHUS) Patients with Long Disease Duration and Chronic Kidney Disease (CKD): 2-Year Results Blood ·Christoph Licht, Petra Muus, Christophe Legendre, Kenneth Douglas, Maryvonne Hourmant, Yahsou Delmas, Maria Herthelius, Antonella Trivelli, Timothy H.J. Goodship, Camille L. Bedrosian, Chantal Loirat	2012	6
9	Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or Lenalidomide Biology of Blood and Marrow Transplantation ·Florent Malard, Nicolaus Kröger, Ian H Gabriel, Kai Hübel, Jane F. Apperley, Grzegorz Basak, Kenneth Douglas, Catarina Geraldes, Ozren Jakšić, Zdeněk Kořı́stek, Francesco Lanza, Roberto M. Lemoli, Gábor Mikala, Dominik Selleslag, Nina Worel, Mohamad Mohty, Rafael F. Duarte	2011	32
10	Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA Bone Marrow Transplantation ·Kenneth Douglas, Anne Parker, Patrick Hayden, Amin Rahemtulla, Alessandra D’Addio, Roberto M. Lemoli, Kamakshi V. Rao, Michael B. Maris, Antonio Pagliuca, Joseph P. Uberti, Christoph Scheid, Richard Noppeney, Gordon Cook, I. S. Amosova, Nina Worel, Gábor Mikala, Tamás Masszi, Robert L. Taylor, Jonathan Treisman	2011	10
11	Interim analysis of phase II efficacy and safety data for eculizumab in patients with atypical hemolytic uremic syndrome (aHUS) receiving chronic plasma exchange/infusion Molecular Immunology ·Timothy H.J. Goodship, Petra Muus, Christophe Legendre, Kenneth Douglas, M Hourmant, Yahsou Delmas, Maria Herthelius, Antonella Trivelli, C Loirat, Mohammadreza Asadbeigi, علی چاپاریان	2011	3
12	The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF Bone Marrow Transplantation ·Alessandra D’Addio, Antonio Curti, Nina Worel, Kenneth Douglas, Maria Rosa Motta, Simonetta Rizzi, Elisa Dan, Рахимов Б.Г, Valentina Giudice, Hermine Agis, Dr Dipendra Sharma, Richard Soutar, Beatrice Casadei, Michele Baccarani, Roberto M. Lemoli	2010	73
13	Significantly Lower Cryopreservation Volumes for PBSC Collections Using Spectra Optia® Version 5 Software Compared with the MNC Setting on COBE® Spectra, Particularly When Using Plerixafor for Mobilisation Blood ·Mhairi Copland, Michael J. Alcorn, Mohamed G. Abdel-Moneim, A. T. Doig, 姜应龙, Jean-Marcellin Fankam Tchoumbou, Joy Sinclair, Anne Parker, Kenneth Douglas	2010	2
14	Infection frequently triggers thrombotic microangiopathy in patients with preexisting risk factors: A single‐institution experience Journal of Clinical Apheresis ·Kenneth Douglas, Kevin G. Pollock, David Young, Henriette Cornelia Santer-Weststrate, Rachel Green	2010	28
15	Family donor care management: principles and recommendations Bone Marrow Transplantation ·Suzanna M. van Walraven, M Shabir, Zahra Ziba, Kenneth Douglas, David Albert Jones, S J Lee, Michael A. Pulsipher, Jenny Marcela Miranda, Jörg Halter, Bronwen E. Shaw	2009	36
16	U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease British Journal of Dermatology ·Julia Scarisbrick, Peter C. Taylor, Udo Holtick, Jorn Lyseggen, Kenneth Douglas, Gösta Berlin, Eeva Juvonen, Scott Marshall, (unknown)	2008	105
17	Extracorporeal photopheresis improves nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: Three case reports and review of literature Journal of Clinical Apheresis ·Henry Filadelfo Gonzalez Ceballos, Scott Morris, 王利坚, Rachel Green, Kenneth Douglas	2008	44
18	Ideal body weight correlates better with engraftment after PBSC autograft than actual body weight, but is under-estimated in myeloma patients possibly due to disease-related height loss Bone Marrow Transplantation ·PUTRI NUR FADHILAH, Anne Parker, I. Grant McQuaker, Andrew Clark, Emily Farrell, Kenneth Douglas	2007	5
19	Dose escalation therapy in previously untreated patients with multiple myeloma following Z‐Dex induction treatment British Journal of Haematology ·Andrew Clark, Kenneth Douglas, Hasti Parang, I. Grant McQuaker, Anne Parker, P Tansey, Ian M. Franklin, Gordon Cook	2002	7
20	A Comparison of Mesoridazine and Chlorpromazine in Chronic Psychiatric Patients PubMed ·Kenneth Douglas, promoteur Chabane	1969	6

About Kenneth Douglas

Kenneth Douglas is a scholar working on Transplantation, Hematology, Physiology, Nephrology and Immunology, having authored 23 papers that have together received 886 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (8 papers), Complement system in diseases (7 papers), Multiple Myeloma Research and Treatments (6 papers), Acute Myeloid Leukemia Research (4 papers), Renal Diseases and Glomerulopathies (4 papers), Adenosine and Purinergic Signaling (4 papers), T-cell and Retrovirus Studies (2 papers) and Renal Transplantation Outcomes and Treatments (2 papers). The work is most often cited by research in Hematology (423 citations), Nephrology (235 citations), Transplantation (86 citations), Immunology (462 citations) and Physiology (81 citations). Kenneth Douglas has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Peter C. Taylor, Maria Herthelius, Maryvonne Hourmant, Timothy H.J. Goodship, Chantal Loirat, Yahsou Delmas, Camille L. Bedrosian, Christoph Licht, Petra Muus and Christophe Legendre. Their work appears in journals such as Bone Marrow Transplantation, Journal of Clinical Apheresis, Blood, British Journal of Haematology and Transfusion.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact